CHA Biotech Co. Ltd (085660) — Cash Flow Reinvestment Rate

Latest as of June 2024: 3.80x

CHA Biotech Co. Ltd (085660) has a Cash Flow Reinvestment Rate of 3.80x as of June 2024, reinvesting ₩52.39 Billion (capex ₩34.71 Billion plus investments ₩17.68 Billion) from operating cash flow of ₩13.77 Billion. Check 085660 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

3.80x
(Capex + Investments) / Operating CF

Total Reinvested

₩52.39 Billion
Capex + Investments

Operating Cash Flow

₩13.77 Billion
KRW

Capital Expenditures

₩34.71 Billion
KRW

CHA Biotech Co. Ltd Cash Flow Reinvestment Rate (2009–2023)

Historical reinvestment intensity for CHA Biotech Co. Ltd across 13 annual periods. Explore CHA Biotech Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for CHA Biotech Co. Ltd (2009–2023)

Year-by-year capital reinvestment analysis for CHA Biotech Co. Ltd. For live market cap and broader valuation context, see market cap of CHA Biotech Co. Ltd.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2023 13.73x ₩158.10 Billion ₩11.51 Billion ₩74.38 Billion ▲ +35.2%
2021 10.16x ₩225.77 Billion ₩22.23 Billion ₩115.46 Billion ▲ +197.5%
2020 3.41x ₩160.41 Billion ₩47.00 Billion ₩126.23 Billion ▼ -42.8%
2019 5.97x ₩150.74 Billion ₩25.24 Billion ₩107.77 Billion ▲ +427.0%
2018 1.13x ₩85.43 Billion ₩75.38 Billion ₩78.14 Billion ▼ -75.9%
2017 4.70x ₩56.46 Billion ₩12.01 Billion ₩36.91 Billion ▼ -57.2%
2016 10.98x ₩124.04 Billion ₩11.29 Billion ₩34.13 Billion ▲ +1267.4%
2015 0.80x ₩49.69 Billion ₩61.86 Billion ₩31.36 Billion ▲ +91.4%
2013 0.42x ₩27.85 Billion ₩66.35 Billion ₩27.85 Billion ▼ -37.7%
2012 0.67x ₩30.84 Billion ₩45.77 Billion ₩30.84 Billion ▼ -8.2%
2011 0.73x ₩25.48 Billion ₩34.69 Billion ₩25.48 Billion ▲ +22.5%
2010 0.60x ₩25.22 Billion ₩42.07 Billion ₩25.22 Billion ▼ -19.7%
2009 0.75x ₩17.93 Billion ₩24.02 Billion ₩17.93 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow